Half-LifeAdministration, OralArea Under CurveBiological AvailabilityMetabolic Clearance RateInjections, IntravenousPharmacokineticsDrug InteractionsDose-Response Relationship, DrugDrug Administration ScheduleInfusions, IntravenousTissue DistributionCross-Over StudiesChromatography, High Pressure LiquidFood-Drug InteractionsTime FactorsRats, Sprague-DawleyDrug Administration RoutesInjections, IntramuscularBiotransformationInjections, SubcutaneousProdrugsInfusions, ParenteralDouble-Blind MethodUnited States Food and Drug AdministrationRats, WistarAdministration, RectalNeoplasmsCytochrome P-450 CYP3AAntineoplastic AgentsModels, BiologicalAnti-Bacterial AgentsKineticsAdministration, IntravenousLiverDogsInjections, IntraperitonealDrug CombinationsTreatment OutcomeDrug Therapy, CombinationDelayed-Action PreparationsAdministration, IntranasalAbsorptionDisease Models, AnimalRitonavirCapsulesAnti-Infective AgentsTherapeutic EquivalencyAntifungal AgentsMidazolamTriazolesStereoisomerismMacaca fascicularisDrug Dosage CalculationsIntestinal AbsorptionMaximum Tolerated DoseQuinolinesKidneyCephalosporinsKetoconazoleChemistry, PharmaceuticalBileTabletsRabbitsAnalgesics, OpioidAdministration, TopicalAntineoplastic Agents, PhytogenicAntibodies, MonoclonalBody WeightDrug Evaluation, PreclinicalHealthy VolunteersDrug MonitoringAdministration, CutaneousAnti-HIV AgentsPyridinesMice, Inbred C57BLPyrimidinonesP-GlycoproteinBlood ProteinsPlasmaMice, Inbred BALB CPiperidinesDrug EvaluationDrug CarriersRandom AllocationHIV Protease InhibitorsChromatography, LiquidAdministration, InhalationAryl Hydrocarbon HydroxylasesSuspensionsDrug Delivery SystemsSulfonamidesDrug ToleranceAdministration, SublingualEnzyme InhibitorsHerb-Drug InteractionsBlisterPiperazinesCytochrome P-450 Enzyme SystemPopulation